Faculdade de Ciências Médicas da Santa Casa de São Paulo, Responsável pela Disciplina de Gastroenterologia Pediátrica, São Paulo 01234-001, Brazil.
Disciplina de Gastroenterologia Pediátrica, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo 04023-062, Brazil.
Nutrients. 2021 May 13;13(5):1634. doi: 10.3390/nu13051634.
Constipation is a frequent problem in children. We evaluated the effect of a mixture (polydextrose [PDX] and fructooligosaccharide [FOS]) in children with constipation. We performed a prospective interventional study with a mixture (PDX 4.17 g and FOS 0.45 g) in a daily dose of food supplement. The intervention lasted 45 days, with visits at 15, 30, and 45 days after administration. The sample comprised 105 patients, of whom 77 completed the intervention. A statistically significant reduction in the frequency of symptoms was observed at the end of the study. The frequency of children with fewer than three bowel movements per week dropped from 59.7% to 11.7%, and there was a decrease in the frequency of Bristol type 1 and 2 dry stools (68.8% to 7.8%), pain on defecation (79.2% to 10.4%), and fear of defecation (68.8% to 3.9%). The proportion of children with abdominal pain symptoms decreased from 84.2% to 2.6% at the end of the study. A relevant limitation of the present study was the lack of a control group treated with placebo. The administration of the PDX/FOS mixture was accompanied by a significant reduction in the frequency of constipation symptoms of the children evaluated. The tolerability was very good, and the rate of adverse effects was low.
便秘是儿童的常见问题。我们评估了混合物(聚葡萄糖[PDX]和低聚果糖[FOS])对便秘儿童的影响。我们进行了一项前瞻性干预研究,采用每日剂量的食物补充剂(PDX 4.17 g 和 FOS 0.45 g)混合物。干预持续 45 天,在给药后 15、30 和 45 天进行随访。该样本包括 105 名患者,其中 77 名完成了干预。研究结束时观察到症状频率明显降低。每周排便次数少于三次的儿童比例从 59.7%降至 11.7%,布里斯托 1 型和 2 型干便的频率下降(68.8%降至 7.8%),排便时疼痛(79.2%降至 10.4%)和排便恐惧(68.8%降至 3.9%)。研究结束时,腹痛症状的儿童比例从 84.2%降至 2.6%。本研究的一个重要局限性是缺乏安慰剂治疗的对照组。PDX/FOS 混合物的给药伴随着评估儿童便秘症状频率的显著降低。耐受性非常好,不良反应发生率低。